儿科感染与炎症的放射性核素显像新趋势:聚焦FDG PET/CT与免疫反应性
本文综述儿科不明原因发热与不明原因炎症的近期文献,重点阐述噬血细胞性淋巴组织细胞增生症综合征及免疫检查点抑制剂相关免疫相关不良事件在18F-FDG PET/CT上的显像表现,强调识别这些「偶然」发现对避免误判为肿瘤至关重要。
要点
- 儿科18F-FDG PET/CT最常见适应证为肿瘤显像,感染、炎症及自身免疫过程多为偶然发现。
- 不明原因发热或炎症是感染/炎症作为主要适应证进行FDG PET/CT显像的情形。
- 识别噬血细胞性淋巴组织细胞增生症综合征和检查点抑制剂相关免疫相关不良事件的FDG PET/CT表现很重要。
核心结论
- 儿科FDG PET/CT上偶然发现的感染、炎症及自身免疫过程,判读时须避免误归为肿瘤性病变,这是最重要的。
研究设计与样本
- 本文为综述,复习儿科不明原因发热及不明原因炎症的近期文献,并聚焦免疫反应性增高的两类特定疾病的18F-FDG PET/CT表现。
主要发现
- 儿科核医学常规实践中,FDG PET/CT上检出的大多数感染、炎症和自身免疫过程(不明原因发热或炎症的显像除外)为偶然发现,并非图像采集的主要适应证。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The most common indication for 18F-FDG PET/CT is tumor imaging, which may be performed for initial diagnosis, staging, therapeutic response monitoring, surveillance, or suspected recurrence. In the routine practice of pediatric nuclear medicine, most infectious, inflammatory, and autoimmune processes that are detected on 18F-FDG PET/CT imaging - except for imaging in fever or inflammation of unknown origin - are coincidental and not the main indication for image acquisition. However, interpreting these "coincidental" findings is of utmost importance to avoid erroneously attributing these findings to a neoplastic process. We review the recent literature on fever of unknown origin as well as inflammation of unknown origin in pediatrics and then focus on the 18F FDG PET/CT imaging findings seen in two specific entities with increased immune reactivity: hemophagocytic lymphohistiocytosis syndrome and the immune-related adverse events associated with checkpoint inhibitors. We will subsequently close with two sections highlighting related topics and relevant references for further reading.
引用
- Khalatbari H, Shulkin BL, Parisi MT, et al. Emerging Trends in Radionuclide Imaging of Infection and Inflammation in Pediatrics: Focus on FDG PET/CT and Immune Reactivity. Semin Nucl Med. 2022. PMID: 36307254. doi:10.1053/j.semnuclmed.2022.10.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。